Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in LGND — Ligand Pharmaceuticals Inc

CIK 1000275 TORONTO, A6
Back to LGND Full portfolio

Position in LGND

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$37,637,782
+$15,368,224 QoQ
Shares Held
119,073
+6.8% QoQ
Ownership
0.597%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#44
of 415 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LGND Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,118,794,122 across 427 Biotechnology names. LGND ranks #10 (1.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 6,182,479 $490,208,754
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 980,259 $486,924,048
3 ALNY
Alnylam Pharmaceuticals, Inc.
 875,859 $263,659,830
4 INCY
Incyte Corp
 1,132,050 $128,329,182
5 REGN
Regeneron Pharmaceuticals, Inc.
 174,515 $108,817,078
6 MRNA
Moderna, Inc.
 944,457 $66,140,319
7 INSM
INSMED Inc
 416,487 $44,405,840
8 HALO
Halozyme Therapeutics, Inc.
 545,761 $42,716,712

All Filings in LGND

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $37,637,782 119,073
2026-03-31 $22,269,558 111,543
2025-12-31 $20,570,057 108,796
2025-09-30 $18,332,746 103,493
2025-06-30 $1,075,410 9,460
2025-03-31 $643,455 6,120
2024-12-31 $521,174 4,864
2024-09-30 $413,368 4,130
2024-06-30 $298,195 3,539
2024-03-31 $167,032 2,285
2023-12-31 $499,080 6,988
2023-09-30 $316,195 5,277
2023-06-30 $358,768 4,976
2023-03-31 $217,809 2,961
2022-12-31 $332,061 4,971
2022-09-30 $182,035 2,114
2022-06-30 $167,821 1,881
2022-03-31 $305,634 2,717
2021-12-31 $816,936 5,289
2021-09-30 $577,479 4,145
2021-06-30 $2,905,332 22,146
2021-03-31 $3,084,060 20,230
2020-12-31 $2,977,531 29,940
2020-09-30 $2,978,939 31,252
2020-06-30 $3,491,393 31,215
2020-03-31 $2,089,605 28,735